Ascentage Pharma Group Internat (AAPG) earnings & catalyst calendar
Updated
Next report: · 77d away
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Ascentage Pharma Group Internat has 0 beats and 0 misses across of the last 1 reported quarter. Current engine verdict: HOLD at 6.5/10.
EPS beat / miss history
| Quarter | Reported | Est. EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
| Q2 '25 | — | — | — | UNKNOWN |
EPS only — revenue + guidance fields pending pipeline extraction (growth/123 backlog).
What the streak says
Ascentage Pharma Group Internat has reported 0 beats and 0 misses across the last 1 quarter. with the most recent report at Q2 '25 coming in — vs estimate. The current engine read is HOLD at score 6.5. The earnings track record above is one input among ten dimensions feeding the verdict assembly — see the per-dimension breakdown for which dimensions actually drove this verdict. Active engine warnings: V9 Gate Failed: MOMENTUM:3.4<4.5, V9 Gate Failed: DEATH_CROSS:HARD_BLOCK. Engine trigger: Mixed signals. Hold existing position.
Watch nextNext report: 2026-08-19 (77d away). The watch-item is whether a re-acceleration off the 0% miss restores the catalyst-dimension inputs. Another miss reinforces the current verdict band.
Upcoming catalysts
No upcoming dated catalysts in the current snapshot.
Sources: SEC EDGAR (8-K), Finnhub (earnings), corporate IR. Public-record dates only — no projected events.